AdministrationAgreement-v1.0.1(2018EN)

Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.AdministrationAgreement
Version: 1.0.1
HCIM Status:Final
Release: 2018
Release status: Prepublished
Release date: 01-10-2018

---

Back to HCIM list

Metadata

DCM::CoderList	Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name	*
DCM::ContactInformation.Telecom
DCM::ContentAuthorList	Projectgroep Medicatieproces
DCM::CreationDate	1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage	nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name	PM
DCM::EndorsingAuthority.Telecom
DCM::Id	2.16.840.1.113883.2.4.3.11.60.40.3.9.8
DCM::KeywordList	Medicatie, Toediening
DCM::LifecycleStatus	Final
DCM::ModelerList	Architectuurgroep Registratie aan de Bron
DCM::Name	nl.zorg.Toedieningsafspraak
DCM::PublicationDate	01-10-2018
DCM::PublicationStatus	Prepublished
DCM::ReviewerList	Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate	31-12-2017
DCM::Superseeds	nl.zorg.MedicatieVerstrekking-v3.0
DCM::Version	1.0.1
HCIM::PublicationLanguage	EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)

ZIB-643

Kleine tekstuele verbeteringen

Concept

An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.

Purpose

The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.

Information Model

Type	Id	Concept						Card.	Definition	DefinitionCode	Reference
	NL-CM:9.8.20132	AdministrationAgreement							Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model.
	NL-CM:9.8.22097		Supplier::HealthProfessional					0..1	The supplier (pharmacist) that entered the administration agreement.		HealthcareProvider
	NL-CM:9.8.20237		MedicineForAdministrationAgreement::FarmaceuticalProduct					1	Medicine in the AdministrationAgreement.		PharmaceuticalProduct
	NL-CM:9.8.22098		InstructionsForUse					0..1	Instructions for administering the medication, e.g. dose and route of administration.		InstructionsForUse
	NL-CM:9.8.20133		AdministrationAgreementDateTime					0..1	The time at which the agreement was made.
	NL-CM:9.8.22499		AgreementReason					0..1	Reason for this agreement. This will often be the same reason as the one for the medication agreement. This field has the option to - if applicable - enter a specific reason for the administration agreement. Examples include: substitution, transfer to GDS, patient request for different product, etc.
	NL-CM:9.8.22660		PeriodOfUse					1	Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original administration agreement. The end date indicates from when the medication is to be discontinued. Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days. End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date. With medication for an indefinite period only a start date is indicated.		TimeInterval
	NL-CM:9.8.22394		MedicationAgreement					0..1	Relationship to the medication agreement on which the administration agreement is based.		MedicationAgreement
	NL-CM:9.8.22498		AdministrationAgreementStopType					0..1	Stop type, the manner in which this medication is discontinued (temporary or definitive).		AdministrationAgreementStopTypeCodeList
	NL-CM:9.8.23034		CanceledIndicator					0..1	In the event of an error correction, this indicator is to be put on for the incorrect agreement.
	NL-CM:9.8.23284		AdministrationAgreementAdditionalInformation					0..*	Additional information includes details on the structure of the agreement made. This element mainly contains information that until now has been structured with ZZ rules. The medication-related topics that are now supported by the ZZ rules are best supported with a system functionality. A process has been started for this by Z-index/KNMP. For now, the following list will be used. This list will be replaced by a thesaurus in the G standard at a later stage.		AdministrationAgreementAdditionalInformationCodeList
	NL-CM:9.8.22275		Comment					0..1	Comments on the administration agreement.	48767-8 Annotation comment [Interpretation] Narrative

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page

Example Instances

Only available in Dutch

ToedieningsAfspraakDatumTijd	Gebruiksperiode			GeneesmiddelBijToedieningsafspraak	Verstrekker	GeannuleerdIndicator	ToedieningsafspraakStoptype
	Ingangsdatum	Einddatum	Duur	ProductCode	Zorgaanbieder
2-5-2012 12:14:09	02-05-12		4 weken	Paracetamol tablet 500 mg	Apotheek De Gulle Gaper
10-9-2015 9:16:31			5 dagen	Pantoprazol injpdr 40 mg fl	Apotheek De Gulle Gaper	Ja
19-9-2014 7:12:59	19-09-14	18-12-14		Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml	Poli-apotheek Het Ziekenhuis
30-8-2013 8:41:43	01-08-13	30-08-13		Prednison 5 mg	Poli-apotheek Het Ziekenhuis		Definitief

Gebruiksinstructie
Omschrijving	ToedieningsWeg	HerhaalperiodeCyclischSchema	Doseerinstructie
			Doseerduur	Dosering|Keerdosis	Toedieningsschema|Frequentie|Interval|Toedientijd|Weekdag|Dagdeel	Zo nodig
Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag	oraal	1	4 weken	1 stuk	max. 4x/dag	Bij pijn
Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st)	iv			40 mg (=1 st)	1x per dag om 8.00 uur
Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml)	subcutaan			2500 IE (=0,2 ml)	1x per dag om 18.00 uur
Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken.	oraal	1

Valuesets

AdministrationAgreementAdditionalInformationCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.2

Binding: Extensible

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Geneesmiddel niet verstrekt	1	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Geneesmiddel niet verstrekt
Niet leverbaar	2	Voorlopige aanvullende  informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Niet leverbaar
Medicatieafspraak gewijzigd: substantie	3	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Medicatieafspraak gewijzigd: substantie
Medicatieafspraak gewijzigd: dosering	4	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Medicatieafspraak gewijzigd: dosering
Medicatieafspraak gewijzigd: farmaceutische vorm	5	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Medicatieafspraak gewijzigd: farmaceutische vorm
Medicatieafspraak gewijzigd: verwisseling van persoon	6	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Medicatieafspraak gewijzigd: verwisseling van persoon
Machtiging aangevraagd	7	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Machtiging aangevraagd
Machtiging afgewezen	8	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Machtiging afgewezen
Machtiging in gebruik nemen	9	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Machtiging in gebruik nemen
Gebruiksinstructie gegeven	10	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Gebruiksinstructie gegeven
Controle inhalatietechniek	11	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Controle inhalatietechniek
Meter periodieke controle	12	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Meter periodieke controle
Pen controle/omruil	13	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Pen controle/omruil
Bijwerking besproken	14	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Bijwerking besproken
Afhandeling bijwerking niet-lareb	15	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Afhandeling bijwerking niet-lareb
Melding lareb	16	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Melding lareb
Medicatiebewaking OT	17	Voorlopige aanvullende informatie toedieningsafspraak	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999	Medicatiebewaking OT

AdministrationAgreementStopTypeCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1

Binding: Extensible

Conceptname	Conceptcode	Codesystem name	Codesystem OID	Description
Tijdelijk	1	StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief	2	StopType	2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1	Het staken van een bestaande medicamenteuze behandeling.

This information model in other releases

• Release 2017, (Version 1.0.1)
• Prerelease 2019-2, (Version 1.0.2)
• Release 2020, (Version 1.0.3)
• Prerelease 2021-2, (Version 1.1)
• Prerelease 2022-1, (Version 2.0)
• Prerelease 2023-1, (Version 2.1)
• Prerelease 2024-1, (Version 3.0)

Information model references

This information model refers to

• HealthcareProvider-v3.2
• InstructionsForUse-v1.1.1
• MedicationAgreement-v1.0.1
• PharmaceuticalProduct-v2.0
• TimeInterval-v1.0

This inforation model is used in

• MedicationAdministration2-v1.0.1

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

• HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
• HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR

Downloads

This information model is also available as pdf file or as spreadsheet

About this information

The information in this wikipage is based on Prerelease 2018 #1
SNOMED CT and LOINC codes are based on:

• SNOMED Clinical Terms version: 20180731 [R] (July 2018 Release)
• LOINC version 2.64

Conditions for use are located on the mainpage
This page is generated on 01/11/2018 17:37:54 with ZibExtraction v. 2.0.6879.31307

---

Back to HCIM list